title: Reply to Dr. Charlebois et Al. (Clin infect dis 2002; 34:425-33).
authors.forename: P
authors.initials: P
authors.lastname: Daly
authors.forename: E A
authors.initials: EA
authors.lastname: Bryce
authors.forename: J
authors.initials: J
authors.lastname: Buxton
mesh_terms: D002170:Canada / Q000453:epidemiology; D005260:Female; D006801:Humans; D008017:Life Expectancy; D008297:Male; D016106:Methicillin Resistance; D015995:Prevalence; D012703:Serotyping; D013203:Staphylococcal Infections / Q000453:epidemiology; D013211:Staphylococcus aureus / Q000187:drug effects*